Epigenetics and Therapeutic Strategies
33 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Combining DNA methylation inhibitors and ______ inhibitors is a clinically advanced epigenetic therapy.

HDAC

Cytotoxic therapies directly kill rapidly dividing cells, including ______ cells.

cancer

Epigenetic therapies can help reverse the epigenetic ______ that leads to chemotherapy resistance.

silencing

Combining epigenetic therapies with conventional cytotoxic therapies can improve cancer treatment ______.

<p>outcomes</p> Signup and view all the answers

5-Aza-CR is known for reversing ______-mediated silencing.

<p>methylation</p> Signup and view all the answers

Epigenetics refers to changes in gene activity that don't involve alterations to the ______ sequence itself.

<p>DNA</p> Signup and view all the answers

Key epigenetic mechanisms include DNA methylation, histone modifications, and ______ positioning.

<p>nucleosome</p> Signup and view all the answers

DNA methylation involves adding a ______ group to a cytosine base in DNA.

<p>methyl</p> Signup and view all the answers

Histones are proteins that DNA wraps around, and they can be modified with various chemical ______.

<p>groups</p> Signup and view all the answers

In some cancers, histone modifications are ______, contributing to abnormal gene activity.

<p>altered</p> Signup and view all the answers

A global loss of DNA methylation (hypomethylation) in cancer cells leads to genomic ______.

<p>instability</p> Signup and view all the answers

5-Azacytidine and its deoxy derivative are approved drugs that act as DNA methylation ______.

<p>inhibitors</p> Signup and view all the answers

At higher doses, methylation inhibitors like 5-Azacytidine induce ______.

<p>cytotoxicity</p> Signup and view all the answers

Histone deacetylase (HDAC) inhibitors increase histone ______ levels, promoting gene reactivation.

<p>acetylation</p> Signup and view all the answers

Lysine-specific demethylase 1 (LSD1) removes methyl groups from ______, affecting gene expression.

<p>H3K4</p> Signup and view all the answers

EZH2 catalyzes H3K27 ______, which acts as a repressive mark.

<p>methylation</p> Signup and view all the answers

DZNep is a potential EZH2 inhibitor that depletes ______ components.

<p>PRC2</p> Signup and view all the answers

MicroRNAs primarily act by binding to ______, leading to gene silencing.

<p>messenger RNAs</p> Signup and view all the answers

Dysregulation of miRNA expression is common in many diseases, including ______.

<p>cancer</p> Signup and view all the answers

The combined epigenetic therapies aim to tackle the disease on ______ fronts.

<p>multiple</p> Signup and view all the answers

Current HDAC inhibitors often lack ______ and can lead to side effects.

<p>specificity</p> Signup and view all the answers

Signaling pathways such as the PI3K/Akt pathway can modulate the activity of ______.

<p>EZH2</p> Signup and view all the answers

The mechanisms of miRNAs can lead to either mRNA ______ or translational repression.

<p>degradation</p> Signup and view all the answers

The global hypomethylating effects can activate ______ and increase genomic instability.

<p>oncogenes</p> Signup and view all the answers

Azanucleosides' mechanism of action is dependent on DNA replication in the ______ phase of the cell cycle.

<p>S</p> Signup and view all the answers

DNA methylation levels can return to pre-treatment levels after the drugs are ______.

<p>withdrawn</p> Signup and view all the answers

Histones are proteins that act as spools around which ______ winds.

<p>DNA</p> Signup and view all the answers

Acetylation generally associates with gene ______.

<p>activation</p> Signup and view all the answers

H3K4 methylation is typically associated with active ______.

<p>promoters</p> Signup and view all the answers

Histone modifications contribute to the complex ______ code that influences gene expression.

<p>histone</p> Signup and view all the answers

Phosphorylation, ubiquitylation, and sumoylation are examples of ______ modifications.

<p>histone</p> Signup and view all the answers

Histone-modifying enzymes are considered potential therapeutic ______.

<p>targets</p> Signup and view all the answers

The basic units of chromatin, where DNA is compacted, are called ______.

<p>nucleosomes</p> Signup and view all the answers

Study Notes

Epigenetic Modifications as Therapeutic Targets

  • Epigenetics involves changes in gene activity without altering DNA sequence. These changes are heritable and reversible, making them potential therapeutic targets.
  • Key epigenetic mechanisms include DNA methylation, histone modifications, and nucleosome positioning.
  • DNA Methylation: Adding a methyl group to a cytosine base often silences the associated gene. In cancer, tumor suppressor genes are frequently abnormally methylated, hindering their function.
  • Histone Modifications: Histones package DNA. Modifications like acetylation or methylation affect DNA packaging, altering gene expression. Abnormal histone modifications contribute to some cancers.
  • Nucleosome Positioning: The location of nucleosomes along DNA impacts which genes are accessible for transcription. Changes in nucleosome positioning contribute to disease.
  • Epigenetic Abnormalities: Linked to a variety of conditions beyond cancer, including diabetes and neurological disorders.

DNA Methylation - Mechanism and Therapeutic Use

  • Cancer is characterized by global hypomethylation (reduced DNA methylation) but specific promoter hypermethylation (increased methylation), often targeting tumor suppressor genes within CpG islands.
  • 5-Azacytidine (5-Aza-CR) and 5-Aza-2'-deoxycytidine (5-Aza-CdR, decitabine) are approved DNA methylation inhibitors.
  • These nucleoside analogs incorporate into DNA, inhibiting DNA methyltransferase (DNMT) enzymes, causing demethylation.
  • Zebularine and S110 are other methylation inhibitors with potentially enhanced profiles.
  • Challenges: Lack of specificity; global hypomethylation can activate oncogenes and increase genomic instability. Also, these drugs are dependent on DNA replication for activity (S-phase), limiting their effectiveness against slower-growing cancers.

Histone Modifications - The Basics

  • Histones are proteins around which DNA is wound.
  • Histone modifications, such as acetylation (adding acetyl groups) and methylation (adding methyl groups), are vital for gene expression regulation.
  • Acetylation relaxes chromatin structure, promoting gene expression.
  • Methylation can either activate or repress expression. Specific combinations of modifications form a complex 'histone code'.
  • Other modifications include phosphorylation, ubiquitination, and sumoylation.
  • Histone modifiers (e.g., HDACs, LSD1, EZH2) are potential therapeutic targets.

Therapeutic Targets - Inhibitors

  • Histone Deacetylase (HDAC) Inhibitors: Inhibit HDACs (enzymes that remove acetyl groups), increasing histone acetylation, which often reactivates silenced tumor suppressor genes.
  • Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Inhibit LSD1, which removes methyl groups from H3K4 and potentially H3K9, potentially restoring or altering gene expression.
  • EZH2 Inhibitors: Inhibit EZH2, a component of PRC2, impacting H3K27 methylation, crucial for development of effective inhibitors.
  • Inhibitors' specificities influence the spectrum of therapeutic targets.

Combining Epigenetic Therapies

  • Cancers often involve multiple epigenetic alterations. Combination therapies offer a more comprehensive approach to treating multiple disease targets.
  • Combining DNA methylation inhibitors with other epigenetic inhibitors (e.g., HDAC inhibitors) exhibits synergistic effects in various contexts and cancer types.
  • Combining epigenetic therapies with conventional cytotoxic therapies can overcome epigenetic resistance mechanisms and improve efficacy. Epigenetic resistance can arise from drug-sensitivity gene silencing by epigenetics.

Reversibility and Continued Treatment

  • DNA methylation levels can revert to pre-treatment levels after treatment discontinuation, indicating the need for continuous administration.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Description

This quiz explores the crucial role of epigenetic modifications, such as DNA methylation, histone modifications, and nucleosome positioning, as potential therapeutic targets in various diseases. Understand how these epigenetic changes influence gene expression and their implications in conditions like cancer. Dive into the mechanisms driving heritable and reversible genetic activity.

More Like This

Use Quizgecko on...
Browser
Browser